Related Experiment Video
Updated: Nov 26, 2025
14:48
Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
Published on: December 26, 2012
26.8K
Cellular interactions in aspirin-exacerbated respiratory disease
Jana H Badrani1, Taylor A Doherty1,2
1Department of Medicine, University of California San Diego.
Current Opinion in Allergy and Clinical Immunology
|December 11, 2020
Summary
Aspirin-exacerbated respiratory disease (AERD) involves complex cellular interactions, including increased alarmin cytokines and activated immune cells. These pathways promote inflammation, bronchoconstriction, and mucus production characteristic of AERD.
Area of Science:
- Immunology
- Respiratory Medicine
- Pharmacology
Background:
- Aspirin-exacerbated respiratory disease (AERD) is characterized by airway inflammation and hyperresponsiveness.
- Key features include elevated pro-inflammatory eicosanoids and altered cytokine profiles.
Purpose of the Study:
- To review the intricate cellular interactions driving AERD pathogenesis.
- To elucidate how these interactions contribute to the disease mechanisms.
Main Methods:
- Review of recent scientific literature on AERD cellular mechanisms.
- Analysis of eicosanoid and cytokine profiles in AERD patients.
- Examination of immune cell populations and their activation states.
Main Results:
- AERD involves increased alarmin cytokines (IL-33, TSLP) and activated innate lymphoid and plasma cells.
- Pro-inflammatory eicosanoids (CysLTs, PGD2) and hyporesponsiveness to PGE2 are prominent.
- Complex interactions between mast cells, eosinophils, ILC2s, and Th2 cytokines (IL-4, IL-5, IL-13) drive key AERD pathologies.
Conclusions:
- Cellular interactions, particularly involving eicosanoids and alarmin cytokines, are central to AERD.
- These interactions promote bronchoconstriction, eosinophilic inflammation, and mucus production.
- Understanding these pathways offers targets for AERD management.
More Related Videos
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
3.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
840
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
840
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.8K
01:29Acute Respiratory Failure-V
307
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
307
01:29Asthma-I: Introduction
3.1K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.1K
01:20Asthma: Pathogenesis and Management
984
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
984